RET and thyroid gland carcinoma: Thyroid cancers harbor characteristic genetic alterations, including point mutations for proto-oncogenes (BRAF, NRAS, HRAS, KRAS) and chromosomal rearrangements (RET/PTC1, RET/PTC3, PAX8/PPARG), which vary with histologic subtype [3].